Xenon Pharmaceuticals Inc (XENE)
Stock-Based Compensation
$16.73M
Quarterly · Period ending: · USD
XENE Stock-Based Compensation
Latest reported$16.73Mperiod ending
Latest reported$16.73Mperiod ending
XENE Quarterly Stock-Based Comp ($101.00K → $16.73M)
Quarterly stock-based compensation
High-resolution chart · PNG
XENE stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 16,732,000 | |
| 16,894,000 | |
| 14,115,000 | |
| 13,705,000 | |
| 13,713,000 | |
| 12,174,000 | |
| 13,599,000 | |
| 13,002,000 | |
| 14,716,000 | |
| 9,400,000 | |
| 9,182,000 | |
| 8,743,000 | |
| 8,453,000 | |
| 5,994,000 | |
| 5,812,000 | |
| 5,742,000 | |
| 5,208,000 | |
| 3,614,000 | |
| 2,705,000 | |
| 2,643,000 | |
| 2,704,000 | |
| 1,965,000 | |
| 1,610,000 | |
| 0 | |
| 0 | |
| 1,015,000 | |
| 1,357,000 | |
| 612,000 | |
| 464,000 | |
| 491,000 | |
| 575,000 | |
| 687,000 | |
| 700,000 | |
| 663,000 | |
| 593,000 | |
| 567,000 | |
| 598,000 | |
| 478,000 | |
| 519,000 | |
| 636,000 | |
| 414,000 | |
| 592,000 | |
| 474,000 | |
| -191,000 | |
| 3,158,000 | |
| 288,000 | |
| 199,000 | |
| 188,000 | |
| 187,000 | |
| 186,000 | |
| 181,000 | |
| 151,000 | |
| 136,500 | |
| 136,500 | |
| 101,000 | |
| 101,000 |